Sallie Mae to Release Second-Quarter 2024 Financial Results on July 24
Sallie Mae to Release Second-Quarter 2024 Financial Results on July 24
Webcast Scheduled for Wednesday, July 24, at 5:30 p.m. ET
Sallie Mae® (Nasdaq: SLM), formally SLM Corporation, will release second-quarter 2024 financial results after market close on Wednesday, July 24, 2024.
A live audio webcast and presentation slides will be available at SallieMae.com/investors and the hosting website on Wednesday, July 24, 2024, at 5:30 p.m. ET. Investors should log in at least 15 minutes prior to the broadcast.
The earnings news release will be available at SallieMae.com/investors. A replay will also be available on the site.
Sallie Mae (Nasdaq: SLM) believes education and life-long learning, in all forms, help people achieve great things. As the leader in private student lending, we provide financing and know-how to support access to college and offer products and resources to help customers make new goals and experiences, beyond college, happen. Learn more at SallieMae.com. Commonly known as Sallie Mae, SLM Corporation and its subsidiaries are not sponsored by or agencies of the United States of America.
Category: Corporate and Financial
Media
Rick Castellano
302.451.2541
rick.castellano@salliemae.com
Investors
Melissa Bronaugh
571.526.2455
melissa.bronaugh@salliemae.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240710901126/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks